|
End-of-day quote
Shanghai S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 14.39 CNY | +2.49% |
|
+1.20% | -4.51% |
| 10-15 | Huachuang Securities Starts Tasly Pharmaceutical Group at Add with 17.20 Yuan Price Target | MT |
| 10-15 | Tasly Pharmaceutical Wins Clinical Trial Approval for TDX105 Granules | MT |
| Market Cap | 21.5B 3.21B 2.87B 2.65B 2.41B 4.53B 305B 4.6B 31.84B 12.52B 159B 12.06B 11.81B 509B | P/E 2026 * |
16.1x | P/E 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 19.95B 2.98B 2.66B 2.46B 2.24B 4.2B 283B 4.27B 29.55B 11.62B 148B 11.2B 10.96B 473B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.69x |
| Free-Float |
47.11% | Yield 2026 * |
2.7% | Yield 2027 * | 3.27% |
| 1 day | +2.49% | ||
| 1 week | +1.20% | ||
| Current month | +2.79% | ||
| 1 month | +3.82% | ||
| 3 months | -6.44% | ||
| 6 months | +0.98% | ||
| Current year | -4.51% |
| 1 week | 13.92 |  | 14.44 |
| 1 month | 13.64 | | 14.44 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.24 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 10/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 08/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.49% | +1.20% | -9.50% | +5.65% | 3.21B | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | |
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | |
| -0.40% | +3.53% | +19.17% | +46.55% | 286B | |
| -0.37% | +3.11% | -1.26% | +18.23% | 256B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | |
| Average | -0.64% | +2.37% | +28.76% | +59.02% | 390.34B | |
| Weighted average by Cap. | -0.98% | +2.42% | +37.80% | +75.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.63B 1.29B 1.15B 1.07B 969M 1.82B 122B 1.85B 12.79B 5.03B 63.97B 4.84B 4.74B 205B | 9.36B 1.4B 1.25B 1.16B 1.05B 1.97B 133B 2B 13.86B 5.45B 69.33B 5.25B 5.14B 222B |
| Net income | 1.34B 200M 178M 165M 150M 282M 18.96B 286M 1.98B 779M 9.91B 750M 735M 31.68B | 1.58B 236M 211M 195M 177M 333M 22.41B 338M 2.34B 920M 11.71B 887M 868M 37.44B |
| Net Debt | -1.54B -231M -206M -191M -173M -325M -21.89B -331M -2.29B -899M -11.44B -866M -848M -36.57B | -5.71B -854M -761M -705M -641M -1.2B -80.98B -1.22B -8.46B -3.33B -42.33B -3.2B -3.14B -135B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | CN¥14.39 | +2.49% | 15,661,403 |
| 16/10/26 | CN¥14.04 | -0.35% | 15,718,760 |
| 15/10/26 | CN¥14.09 | -1.33% | 15,405,764 |
| 14/10/26 | CN¥14.28 | +2.22% | 15,473,462 |
| 13/10/26 | CN¥13.97 | -1.76% | 12,402,956 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
